XSHE
002582
Market cap634mUSD
Oct 09, Last price
9.64CNY
1D
1.69%
1Q
8.93%
Jan 2017
-45.24%
IPO
-19.58%
Name
Haoxiangni Health Food Co Ltd
Chart & performance
P/E
4.98
P/S
3.25
EPS
1.93
Div yield, %
10.55%
Shrs. gr., 5y
-1.80%
Rev. gr., 5y
0.72%
Revenues
1.33b
-20.48%
Net income
866m
P
CFO
113m
+30.72%
Dividend
Jun 01, 20260.6 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Haoxiangni Health Food Co., Ltd. is a Chinese enterprise dedicated to the full spectrum of health food operations, encompassing research, development, sourcing, manufacturing, and distribution. Its product line features red dates, various nuts, dried fruits, and freeze-dried goods. Established in 1992, the company originally traded as Haoxiangni Jujube Co., Ltd., before officially adopting its current name, Haoxiangni Health Food Co., Ltd., in September 2017. The enterprise maintains its principal office in Xinzheng, China.
Key people
Yanyan Dou
Finance Director, Deputy General Manager, Secretary of the Board · since 2024
Xun Shi
General Manager, Director · since 2024
Juling Shi
Deputy General Manager, Director · since 2015
Minghua Jiang
Director · since 2021
Jia Li
Director · since 2022
Jubin Shi
Chairman of the Board · since 2024
Jingwei Zhang
Deputy General Manager, Director · since 2021
Xiaojun Liao
Independent Director · since 2022
Wenbo Wang
Independent Director · since 2025
Xiaofang Xu
Independent Director · since 2021
Jianjun Zhang
Independent Director · since 2021
Legal address
新郑市薛店镇
郑州市, HA 450000
CN
郑州市, HA 450000
CN
Headquarters
新郑市薛店镇s102与中华路交叉口北
郑州市, HA 450000
CN
郑州市, HA 450000
CN
Address
Xuedian Town，Xinzheng City
Zhengzhou, HA 450000
CN
Zhengzhou, HA 450000
CN
Address
North of the intersection of s102 and Zhonghua Road, Xuedian Town，Xinzheng City
Zhengzhou, HA 450000
CN
Zhengzhou, HA 450000
CN
Other language
Haoxiangni Health Food Co.,Ltd
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||